Skip to main content
. 2014 Mar;133(3):e394–e403. doi: 10.1542/peds.2013-2109

TABLE 6.

Test Characteristics and Predictive Values of Each RBUS “Positive” Threshold for Each of the VCUG Thresholds

Sensitivity (95% CI) Specificity (95% CI) Positive Predictive Value (95% CI) Negative Predictive Value (95% CI)
VCUG-E threshold (any abnormal finding on VCUG)
 RBUS-D (most relaxed criteria) 28.0(25.2–30.9)* / 26.7(23.2–30.4)** 77.3(74.9–79.6)* / 75.1 (71.5–78.5)** 49.2(45.0–53.4)* / 51.0(45.3–56.7)** 57.9(55.5–60.2)* / 51.4(48.1–54.7)**
 RBUS-C 25.5(22.8–28.3)* / 24.2(20.8–27.8)** 78.6(76.2–80.8)* / 76.4 (72.9–79.7)** 48.3(43.9–52.7)* / 49.8(43.9–55.8)** 57.4(55.0–59.7)* / 51.0(47.7–54.3)**
 RBUS-B 19.1(16.7–21.6)* / 18.8(15.7–22.1)** 84.2(82.1–86.2)* / 83.0 (79.8–85.9)** 48.6(43.5–53.7)* / 51.6(44.7–58.5)** 57.1(54.8–59.3)* / 51.3(48.1–54.5)**
 RBUS-A (most stringent criteria) 4.9(3.7–6.5)* / 5.2(3.6–7.4)** 96.7(95.5–97.6)* / 96.1 (94.2–97.5)** 53.8(43.1–64.4)* / 56.4(42.3–69.7)** 56.5(54.4–58.6)* / 51.1(48.2–54.1)**
VCUG-D threshold (urethral findings or major bladder finding or any VUR)
 RBUS-D (most relaxed criteria) 28.1(25.3–31.0)* / 26.6(23.1–30.4)** 77.3(74.9–79.6)* / 75.0(71.4–78.4)** 48.5(44.3–52.7)* / 50.6(44.9–56.3)** 58.6(56.2–61.0)* / 51.5(48.2–54.8)**
 RBUS-C 25.5(22.8–28.4)* / 24.1(20.7–27.7)** 78.6(76.2–80.8)* / 76.3(72.8–79.7)** 47.5(43.2–51.9)* / 49.5(43.6–55.4)** 58.2(55.8–60.5)* / 51.1(47.8–54.4)**
 RBUS-B 19.0(16.6–21.6)* / 18.6(15.6–22)** 84.1(82.0–86.1)* / 82.9(79.7–85.8)** 47.6(42.5–52.7)* / 51.2(44.3–58)** 57.8(55.5–60.0)* / 51.4(48.2–54.6)**
 RBUS-A (most stringent criteria) 4.9(3.7–6.5)* / 5.3(3.6–7.4)** 96.7(95.5–97.6)* / 96.1(94.2–97.5)** 52.7(42.0–63.3)* / 56.4(42.3–69.7)** 57.2(55.1–59.3)* / 51.3(48.4–54.2)**
VCUG-C threshold (urethral findings or major bladder finding or VUR >I)
 RBUS-D (most relaxed criteria) 29.0(26.0–32.1)* / 27.3 (23.6–31.3)** 77.5(75.2–79.7)* / 75.5(72.0–78.7)** 44.8(40.6–49.0)* / 47.7(42.1–53.5)** 63.4(61.1–65.7)* / 55.9(52.6–59.2)**
 RBUS-C 26.5(23.6–29.5)* / 24.7(21.1–28.6)** 78.9(76.6–81.0) / 76.9(73.4–80.0) 44.1(39.8–48.5) / 46.7(40.8–52.6) 63.0(60.7–65.3) / 55.5(52.2–58.7)
 RBUS-B 19.6(17.0–22.4)* / 19.0(15.8–22.6)** 84.3(82.2–86.1) / 83.1(80.0–85.8) 44.0(39.0–49.0) / 47.9(41.1–54.8) 62.5(60.2–64.7) / 55.6(52.4–58.7)
 RBUS-A (most stringent criteria) 5.2(3.8–6.8)* / 5.4(3.6–7.6)** 96.7(95.6–97.6) / 96.1(94.3–97.4) 49.5(38.8–60.1) / 52.7(38.8–66.3) 61.8(59.7–63.9) / 55.3(52.4–58.2)
VCUG-B threshold (urethral findings or major bladder finding or VUR >II)
 RBUS-D (most relaxed criteria) 35.8(31.7–40.0)* / 32.8 (27.9–37.9)** 78.3(76.3–80.2)* / 77.1(74.1–79.9)** 33.5(29.6–37.5)* / 37.1(31.7–42.7)** 80.0(78.0–81.9)* / 73.6(70.5–76.4)**
 RBUS-C 33.1(29.1–37.3)* / 29.9(25.2–35.0)** 79.8(77.9–81.7)* / 78.6(75.7–81.3)** 33.4(29.4–37.6)* / 36.6(31.0–42.4)** 79.7(77.7–81.5)* / 73.1(70.1–76.0)**
 RBUS-B 25.2(21.5–29.1)* / 23.1(18.8–27.8)** 85.2(83.5–86.9)* / 84.3(81.7–86.7)** 34.2(29.5–39.1)* / 37.7(31.2–44.5)** 78.9(77.0–80.7)* / 72.7(69.8–75.4)**
 RBUS-A (most stringent criteria) 7.8(5.6–10.4)* / 7.4(4.9–10.7)** 97.1(96.2–97.8)* / 96.6(95.1–97.7)** 45.1(34.6–55.8)* / 47.3(33.7–61.2)** 77.5(75.7–79.3)* / 71.7(69.0–74.3)**
VCUG-A threshold (urethral findings or major bladder finding or VUR >III)
 RBUS-D (most relaxed criteria) 54.7(46.0–63.3)* / 54.9(42.7–66.8)** 76.9(75.1–78.7)* / 76.1(73.5–78.5)** 13.3(10.6–16.4)* / 12.6(9.1–16.8)** 96.3(95.3–97.2)* / 96.4(95.0–97.5)**
 RBUS-C 53.3(44.6–61.9)* / 53.5(41.3–65.5)** 78.7(76.9–80.5)* / 78.0(75.5–80.4)** 13.9(11.1–17.2)* / 13.2(9.5–17.7)** 96.3(95.3–97.1)* / 96.4(95.0–97.5)**
 RBUS-B 44.5(36.0–53.3)* / 46.5(34.5–58.7)** 84.5(82.9–86.1)* / 83.9(81.7–86.0)** 15.7(12.2–19.7)* / 15.3(10.8–20.9)** 95.9(94.9–96.8)* / 96.2(94.8–97.3)**
 RBUS-A (most stringent criteria) 18.2(12.2–25.7)* / 18.3(10.1–29.3)** 96.9(96.1–97.6)* / 96.3(95.0–97.3)** 27.5(18.6–37.8)* / 23.6(13.2–37.0)** 94.8(93.8–95.7)* / 94.9(93.5–96.1)**

See Table 2 for explanation of RBUS threshold criteria. *Values among children age <120 mo with history of UTI as indication for imaging (N = 2259). **Values among children age 2–24 mo with initial febrile UTI as the indication for GU imaging (N = 1203). CI, 95% confidence interval.